What is Wavely Diagnostics?
Wavely Diagnostics operates at the intersection of mobile technology and pediatric healthcare, positioning itself as a critical player in the evolving telehealth landscape. By leveraging proprietary algorithms and smartphone-integrated sensors, the company enables clinicians to perform remote assessments that were previously confined to physical office visits. This approach not only reduces the burden on healthcare systems but also democratizes access to specialized pediatric care. As the digital health sector matures, Wavely Diagnostics is carving out a defensible market position by transforming standard mobile devices into sophisticated diagnostic tools, thereby facilitating a more efficient, patient-centric model of care delivery.
How much funding has Wavely Diagnostics raised?
Wavely Diagnostics has raised a total of $3.5M across 2 funding rounds:
Angel/Seed
$2.2M
Other Financing Round
$1.4M
Angel/Seed (2022): $2.2M with participation from Cascade Seed Fund, WXR Fund, WRF Capital, Gaingels Spark Fund, HealthTech Capital, and Ambit Health Ventures
Other Financing Round (2023): $1.4M led by Robin Hood Ventures, WRF Capital, and HealthTech Capital
Key Investors in Wavely Diagnostics
HealthTech Capital
HealthTech Capital is a private investment organization focused on healthtech and digital health startups, providing funding and mentoring since 2010 to foster innovation in healthcare delivery.
WRF Capital
Washington Research Foundation is a leading early-stage investor specializing in life sciences and information technology, focused on commercializing innovations from research institutions.
Robin Hood Ventures
Robin Hood Ventures is a prominent angel investment group based in Philadelphia that provides capital and strategic guidance to high-growth startups in the healthcare IT and life sciences sectors.
What's next for Wavely Diagnostics?
The infusion of capital from the latest financing round is expected to accelerate the company's product development roadmap and expand its clinical validation efforts. Given the current enterprise-level funding context, Wavely Diagnostics is likely shifting its focus toward broader commercial integration with major healthcare providers and health systems. Strategic priorities will likely include scaling its diagnostic platform to cover a wider array of pediatric conditions and navigating the complex regulatory pathways required for widespread adoption. By maintaining its focus on high-fidelity remote diagnostics, the company is well-positioned to capture significant market share as telehealth continues to transition from a convenience-based service to a standard component of modern medical practice.
See full Wavely Diagnostics company page
